Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 101Leukemia 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 95Myelodysplastic Syndromes 83Leukemia, Lymphocytic, Chronic, B-Cell 78Lymphoma, Non-Hodgkin 76Multiple Myeloma 67Hodgkin Disease 67Lymphoma, Mantle-Cell 63Lymphoma 62Lymphoma, Large B-Cell, Diffuse 60Lymphoma, Follicular 59Leukemia, Myeloid, Chronic-Phase 57Lymphoma, B-Cell, Marginal Zone 53Burkitt Lymphoma 53Lymphoma, Large-Cell, Immunoblastic 49Leukemia, Myeloid, Accelerated Phase 48Congenital Abnormalities 48Myeloproliferative Disorders 46Leukemia, Myelomonocytic, Chronic 43Anemia, Refractory, with Excess of Blasts 41Graft vs Host Disease 37Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36Blast Crisis 33Recurrence 32Dendritic Cell Sarcoma, Interdigitating 32Primary Myelofibrosis 27Lymphoma, T-Cell, Cutaneous 27Neoplasms, Plasma Cell 26Waldenstrom Macroglobulinemia 25

Interventions

Kidney Transplantation 3Standard of Care 2tocilizumab 1peginesatide 1orellanine 1hematide 1carfilzomib 1belantamab mafodotin 1Sitagliptin Phosphate 1Practice Guidelines as Topic 1Massage 1Mass Screening 1Immunoglobulin G 1Duration of Therapy 1Disulfides 1Cyclosporine 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Kidney Failure, Chronic × Cyclosporine × Clear all
NCT00854139 2020-03-04

Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)

Massachusetts General Hospital

Phase 1 Completed
10 enrolled
GenitourinaryPlasma cell

Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡